IPS-02001

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameIPS-02001

Drug Alias NameIPS-02 series (InnoPharmaScreen)integrin alpha-V/beta-3/osteopontin interaction inhibitor (InnoPharmaScreen)integrin alpha-V/beta-3/osteopontin antagonists (InnoPharmaScreen)IPS-02001

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIntegrin alpha-V/beta-3 antagonistsOsteopontin antagonists

TargetsOsteopontinIntegrin alpha-V/beta-3

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInnoPharmaScreen Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInnoPharmaScreen Inc

Active IndicationsN/A

Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A